Gliosarcoma  >>  glufosfamide (D 19575)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
glufosfamide (D 19575) / Eleison Pharma
NCT00014300: Glufosfamide in Treating Patients With Recurrent Glioblastoma Multiforme

Completed
2
32
Europe, RoW
glufosfamide
European Organisation for Research and Treatment of Cancer - EORTC
Brain and Central Nervous System Tumors
09/01
 

Download Options